The U.S. EPA announces new 5-year registration for XtendiMax® herbicide, Bayer’s low-volatility dicamba product

St. Louis, October 27, 2020 - Today, the U.S. Environmental Protection Agency (EPA) announced a new 5-year registration for XtendiMax^® herbicide with VaporGrip^® Technology, an important weed-control tool for many U.S. growers. The EPA stated that "With today’s decision, farmers now have the certainty they need to make plans for their 2021 growing season. After reviewing substantial amounts of new information, conducting scientific assessments based on the best available science, and carefully considering input from stakeholders we have reached a resolution that is good for our farmers and our environment."

"We welcome the EPA’s science-based review and registration decision providing growers access to this important tool," said Lisa Safarian, President of Bayer Crop Science North America. "Growers need options, and we are proud of our role in bringing innovations like XtendiMax herbicide forward to help growers safely and successfully protect their crops from tough-to-control weeds."

The new EPA-approved product label for XtendiMax herbicide includes some changes to further ensure growers can use the product successfully. The EPA stated "To manage off-site movement of dicamba, EPA’s 2020 registration features important control measures, including:
• Requiring an approved [volatility reduction] buffering agent (also called a Volatility Reduction Agent or VRA) be tank mixed with OTT dicamba products prior to all applications to control volatility.
• Requiring a downwind buffer of 240 feet and 310 feet in areas where listed species are located.
• Prohibiting OTT application of dicamba on soybeans after June 30 and cotton after July 30.
• Simplifying the label and use directions so that growers can more easily determine when and how to properly apply dicamba."
"Growers have been clear how vitally important this tool is for their weed-management programs," said Alex Zenteno, Bayer dicamba product manager. "The EPA’s strong science-based decision and new measures, including the introduction of VaporGrip^® Xtra Agent, will help growers use the product even more successfully. We look forward to working with growers to ensure they are aware of the new XtendiMax herbicide label and prepared for the upcoming season. We take our stewardship responsibility very seriously, and we will continue to enhance our trainings, resources, and other support heading into 2021."

The new EPA registration for XtendiMax herbicide follows Bayer’s recent launch announcement for XtendFlex^® soybeans, which brings additional yield potential and weed-control flexibility to the Roundup Ready^® Xtend Crop System.

"Now that growers have certainty about the registration of XtendiMax herbicide and availability of XtendFlex soybeans, we are excited for our customers to have an outstanding 2021 season and beyond," said Safarian. "We are committed to the Roundup Ready Xtend Crop System, which will continue to evolve and play an important role in Bayer’s crop protection and seed portfolio going forward."

For more information, visit www.RoundupReadyXtend.com.

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros. For more information, go to www.bayer.com.

Find more information at www.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.